MoneyWorks4Me

Piramal Pharma - Quaterly Results

14 May 2025 Evaluate
The company witnessed a 10.78% growth in the revenue at Rs. 16898.00 millions for the quarter ended March 2025 as compared to Rs. 15253.00 millions during the year-ago period.Profit after tax improved marginally to Rs. 2772.70  millions for the quarter ended March 2025 from Rs. 2730.80 millions of corresponding previous quarter.Operating profit surged to 4560.90 millions from the corresponding previous quarter of 4428.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 16898.00 15253.00 10.78 52857.10 43901.10 20.40 52857.10 43901.10 20.40
Other Income 395.10 531.90 -25.72 2073.50 2020.60 2.62 2073.50 2020.60 2.62
PBIDT 4560.90 4428.30 2.99 12477.90 8199.80 52.17 12477.90 8199.80 52.17
Interest 305.60 276.60 10.48 1145.60 1071.00 6.97 1145.60 1071.00 6.97
PBDT 4255.30 4151.70 2.50 11332.30 7128.80 58.97 11332.30 7128.80 58.97
Depreciation 611.70 525.00 16.51 2220.90 2052.60 8.20 2220.90 2052.60 8.20
PBT 3643.60 3626.70 0.47 9111.40 5076.20 79.49 9111.40 5076.20 79.49
TAX 870.90 895.90 -2.79 2197.40 1164.00 88.78 2197.40 1164.00 88.78
Deferred Tax 175.40 23.50 646.38 203.00 39.20 417.86 203.00 39.20 417.86
PAT 2772.70 2730.80 1.53 6914.00 3912.20 76.73 6914.00 3912.20 76.73
Equity 13243.50 13229.50 0.11 13243.50 13229.50 0.11 13243.50 13229.50 0.11
PBIDTM(%) 26.99 29.03 -7.03 23.61 18.68 26.39 23.61 18.68 26.39
Peers
Company Name CMP
Sun Pharma. Inds. 1846.00
Dr. Reddys Labs. 1229.40
Cipla 1390.60
Lupin 2071.00
Zydus Lifesciences 1216.25
View more..